Your browser doesn't support javascript.
loading
Ability to Generate Patient-Derived Breast Cancer Xenografts Is Enhanced in Chemoresistant Disease and Predicts Poor Patient Outcomes.
McAuliffe, Priscilla F; Evans, Kurt W; Akcakanat, Argun; Chen, Ken; Zheng, Xiaofeng; Zhao, Hao; Eterovic, Agda Karina; Sangai, Takafumi; Holder, Ashley M; Sharma, Chandeshwar; Chen, Huiqin; Do, Kim-Anh; Tarco, Emily; Gagea, Mihai; Naff, Katherine A; Sahin, Aysegul; Multani, Asha S; Black, Dalliah M; Mittendorf, Elizabeth A; Bedrosian, Isabelle; Mills, Gordon B; Gonzalez-Angulo, Ana Maria; Meric-Bernstam, Funda.
Afiliação
  • McAuliffe PF; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.
  • Evans KW; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.
  • Akcakanat A; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.
  • Chen K; Department of Bioinformatics and Computational Science, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.
  • Zheng X; Department of Bioinformatics and Computational Science, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.
  • Zhao H; Department of Bioinformatics and Computational Science, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.
  • Eterovic AK; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.
  • Sangai T; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.
  • Holder AM; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.
  • Sharma C; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.
  • Chen H; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.
  • Do KA; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.
  • Tarco E; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.
  • Gagea M; Department of Veterinary Medicine and Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.
  • Naff KA; Department of Veterinary Medicine and Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.
  • Sahin A; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.
  • Multani AS; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.
  • Black DM; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.
  • Mittendorf EA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.
  • Bedrosian I; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.
  • Mills GB; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.
  • Gonzalez-Angulo AM; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.
  • Meric-Bernstam F; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.
PLoS One ; 10(9): e0136851, 2015.
Article em En | MEDLINE | ID: mdl-26325287
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Resistencia a Medicamentos Antineoplásicos / Xenoenxertos Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Animals / Female / Humans / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Resistencia a Medicamentos Antineoplásicos / Xenoenxertos Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Animals / Female / Humans / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article